vs

Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $57.6M, roughly 1.4× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 7.4%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $-167.0M).

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

HSTM vs PHAT — Head-to-Head

Bigger by revenue
HSTM
HSTM
1.4× larger
HSTM
$79.7M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+86.7% gap
PHAT
94.1%
7.4%
HSTM
More free cash flow
HSTM
HSTM
$180.0M more FCF
HSTM
$13.0M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HSTM
HSTM
PHAT
PHAT
Revenue
$79.7M
$57.6M
Net Profit
Gross Margin
86.7%
Operating Margin
3.0%
Net Margin
Revenue YoY
7.4%
94.1%
Net Profit YoY
71.6%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSTM
HSTM
PHAT
PHAT
Q4 25
$79.7M
$57.6M
Q3 25
$76.5M
$49.5M
Q2 25
$74.4M
$39.5M
Q1 25
$73.5M
$28.5M
Q4 24
$74.2M
$29.7M
Q3 24
$73.1M
$16.4M
Q2 24
$71.6M
$7.3M
Q1 24
$72.8M
Net Profit
HSTM
HSTM
PHAT
PHAT
Q4 25
Q3 25
$6.1M
$-30.0M
Q2 25
$5.4M
$-75.8M
Q1 25
$4.3M
$-94.3M
Q4 24
Q3 24
$5.7M
$-85.6M
Q2 24
$4.2M
$-91.4M
Q1 24
$5.2M
Gross Margin
HSTM
HSTM
PHAT
PHAT
Q4 25
86.7%
Q3 25
87.5%
Q2 25
87.2%
Q1 25
86.9%
Q4 24
87.1%
Q3 24
85.6%
Q2 24
81.2%
Q1 24
Operating Margin
HSTM
HSTM
PHAT
PHAT
Q4 25
3.0%
Q3 25
9.9%
-30.8%
Q2 25
7.9%
-151.7%
Q1 25
6.0%
-276.5%
Q4 24
6.3%
Q3 24
8.9%
-433.0%
Q2 24
6.2%
-1055.4%
Q1 24
7.8%
Net Margin
HSTM
HSTM
PHAT
PHAT
Q4 25
Q3 25
8.0%
-60.5%
Q2 25
7.2%
-191.9%
Q1 25
5.9%
-330.7%
Q4 24
Q3 24
7.8%
-523.3%
Q2 24
5.8%
-1248.6%
Q1 24
7.2%
EPS (diluted)
HSTM
HSTM
PHAT
PHAT
Q4 25
$0.09
Q3 25
$0.20
$-0.41
Q2 25
$0.18
$-1.05
Q1 25
$0.14
$-1.31
Q4 24
$0.16
Q3 24
$0.19
$-1.32
Q2 24
$0.14
$-1.56
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSTM
HSTM
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$36.2M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$354.0M
$-438.2M
Total Assets
$520.4M
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSTM
HSTM
PHAT
PHAT
Q4 25
$36.2M
$130.0M
Q3 25
$53.5M
$135.2M
Q2 25
$52.1M
$149.6M
Q1 25
$77.3M
$212.3M
Q4 24
$59.5M
$297.3M
Q3 24
$57.5M
$334.7M
Q2 24
$46.1M
$276.2M
Q1 24
$52.4M
Total Debt
HSTM
HSTM
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
HSTM
HSTM
PHAT
PHAT
Q4 25
$354.0M
$-438.2M
Q3 25
$349.2M
$-422.5M
Q2 25
$350.6M
$-405.8M
Q1 25
$362.8M
$-338.4M
Q4 24
$359.4M
$-253.6M
Q3 24
$355.5M
$-187.1M
Q2 24
$349.2M
$-233.8M
Q1 24
$344.9M
Total Assets
HSTM
HSTM
PHAT
PHAT
Q4 25
$520.4M
$259.1M
Q3 25
$499.9M
$240.3M
Q2 25
$500.1M
$250.2M
Q1 25
$524.0M
$294.2M
Q4 24
$510.8M
$378.3M
Q3 24
$502.8M
$387.0M
Q2 24
$499.6M
$319.4M
Q1 24
$511.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSTM
HSTM
PHAT
PHAT
Operating Cash FlowLast quarter
$13.2M
$-166.8M
Free Cash FlowOCF − Capex
$13.0M
$-167.0M
FCF MarginFCF / Revenue
16.3%
-290.0%
Capex IntensityCapex / Revenue
0.3%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$59.6M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSTM
HSTM
PHAT
PHAT
Q4 25
$13.2M
$-166.8M
Q3 25
$18.0M
$-14.1M
Q2 25
$5.0M
$-62.7M
Q1 25
$27.1M
$-84.9M
Q4 24
$11.2M
$-266.8M
Q3 24
$19.1M
$-63.6M
Q2 24
$6.5M
$-70.7M
Q1 24
$20.9M
Free Cash Flow
HSTM
HSTM
PHAT
PHAT
Q4 25
$13.0M
$-167.0M
Q3 25
$17.9M
$-14.1M
Q2 25
$2.7M
$-62.8M
Q1 25
$26.0M
$-84.9M
Q4 24
$11.0M
$-266.9M
Q3 24
$18.8M
$-63.6M
Q2 24
$6.3M
$-70.8M
Q1 24
$20.2M
FCF Margin
HSTM
HSTM
PHAT
PHAT
Q4 25
16.3%
-290.0%
Q3 25
23.4%
-28.6%
Q2 25
3.6%
-159.0%
Q1 25
35.4%
-297.9%
Q4 24
14.8%
-899.8%
Q3 24
25.8%
-389.0%
Q2 24
8.8%
-966.2%
Q1 24
27.8%
Capex Intensity
HSTM
HSTM
PHAT
PHAT
Q4 25
0.3%
0.4%
Q3 25
0.1%
0.1%
Q2 25
3.1%
0.2%
Q1 25
1.4%
0.1%
Q4 24
0.3%
0.5%
Q3 24
0.4%
0.3%
Q2 24
0.2%
0.6%
Q1 24
1.0%
Cash Conversion
HSTM
HSTM
PHAT
PHAT
Q4 25
Q3 25
2.96×
Q2 25
0.93×
Q1 25
6.25×
Q4 24
Q3 24
3.34×
Q2 24
1.55×
Q1 24
4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons